Drawing for ARTHROAIDE

USPTO serial 75695665

ARTHROAIDE

Reviewed by CopyMark Law Group

Reg. 2341012Status 713
Filing date
Status date
Registration date
Apr 11, 2000
Examiner
SMITH, BRIDGETT G
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ARTHROAIDE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Nutritional supplements containing herbal supplementsSECTION 18 - CANCELLEDApr 20, 1999

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 21, 2002C18.CANCELLED SECTION 18-TOTAL—
Jun 20, 2002CANTCANCELLATION TERMINATED NO. 999999—
Nov 6, 2000PETCCANCELLATION INSTITUTED NO. 999999—
Apr 11, 2000R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 18, 2000PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 17, 1999NPUBNOTICE OF PUBLICATION—
Sep 25, 1999CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 7, 1999CNEAEXAMINER'S AMENDMENT MAILED—
Aug 26, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance